VCELVericel Corporation

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$182,000-65.1% YoY

Gross Profit

$70,00038.5% margin

Operating Income

-$16M-8884.1% margin

Net Income

-$16M-8761.5% margin

EPS (Diluted)

$-17.84

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$19M

Total Liabilities

$2M

Stockholders' Equity

$17M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$182,000	$522,000	-65.1%
Gross Profit	$70,000	$466,000	-85.0%
Operating Income	-$16M	-$21M	+23.8%
Net Income	-$16M	-$20M	+20.8%

VCEL FY 2009 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena